School of Medicine
Showing 1-10 of 20 Results
-
Jacob Chabon
Postdoctoral Research Fellow, Stanford Cancer Center
Current Research and Scholarly InterestsI am interested in genomics and bioinformatics, with a focus on using cell free DNA (cfDNA) to inform more personalized treatment strategies for cancer patients. My lab uses cfDNA, which is accessible via the circulation, as a non-invasive biomarker to both detect cancer (i.e. screening) and better monitor whether patients are responding to treatment over time (i.e. surveillance).
-
Zinaida Good
Postdoctoral Research Fellow, Stanford Cancer Center
BioZinaida Good, PhD is specializing in computational immunology, cancer immunotherapy, and lymphocyte development. She is a Parker Institute for Cancer Immunotherapy scholar training as a postdoctoral fellow with Profs. Crystal L. Mackall (CAR T cells) and Sylvia K. Plevritis (Cancer Systems Biology) at Stanford University. Here, she is working to define features of successful CAR T cells in patients, and to understand CAR T effects on the tumor microenvironment. During her Ph.D. studies in Computational & Systems Immunology, she trained with Profs. Garry P. Nolan and Sean C. Bendall. Her projects included: (1) predicting clinical outcomes in children with leukemia based on single-cell mass cytometry data, (2) guiding T-cell differentiation in the context of ex vivo expansion for cancer immunotherapy applications, and (3) comparing dimensionality reduction methods for single-cell data. Her background is in immunology (B.Sc. and M.Sc. from University of British Columbia in Vancouver, Canada) and oncology (she worked in Discovery Oncology at Genentech for 2 years). Her long-term interest is in the systems-level events required for a coordinated immune attack against cancer.
-
Zheng Hu
Postdoctoral Research Fellow, Stanford Cancer Center
Current Research and Scholarly InterestsMy interest is applying population genetics approaches to the study of tumor evolution and dynamics with focus on the principles of intratumour heterogeneity, tumor progression, origin of metastasis and drug resistance etc.
